References
- Future Reviews [Internet]. ALSUntangled.com [cited 2024 January]. Available from: https://www.alsuntangled.com/future-reviews/.
- Kaczmarek K. The Portable Neuromodulation Stimulator (PoNS) for neurorehabilitation. Scientia Iranica. 2017;0:0–0.
- De Novo Classification Request for Portable Neuromodulation Stimulator (PoNS) [Internet]. U.S. Food and Drug Administration [cited 2024 January]. Available from: https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN200050.pdf.
- Danilov Y, Kaczmarek K, Skinner K, Tyler M. Cranial Nerve Noninvasive Neuromodulation: New Approach to Neurorehabilitation. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Available from: https://www.ncbi.nlm.nih.gov/books/NBK299239/.
- FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients [Internet]. U.S. Food & Drug Administration [cited 2023 November]. Available from: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-device-improve-gait-multiple-sclerosis-patients
- Tyler ME, Kaczmarek KA, Rust KL, Subbotin AM, Skinner KL, Danilov YP. Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial. J Neuroeng Rehab. 2014;11:79.
- Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke [Internet]. Helius Medical Website [cited 2024 February]. Available from: https://ir.heliusmedical.com/news-releases/news-release-details/helius-medical-technologies-announces-authorization-health-0#:∼:text=PoNS%20is%20also%20authorized%20for,treatment%20(14%20weeks)%20of%20gait
- Tyler M, Skinner K, Prabhakaran V, Kaczmarek K, Danilov Y. Translingual Neurostimulation for the Treatment of Chronic Symptoms Due to Mild-to-Moderate Traumatic Brain Injury. Arch Rehabil Res Clin Transl. 2019;1:100026.
- Ptito A, Papa L, Gregory K, Folmer RL, Walker WC, Prabhakaran V, et al. A Prospective, Multicenter Study to Assess the Safety and Efficacy of Translingual Neurostimulation Plus Physical Therapy for the Treatment of a Chronic Balance Deficit Due to Mild-to-Moderate Traumatic Brain Injury. Neuromodulation. 2021;24:1412–21.
- Galea M, Lizama E, Bastani A, Panisset M, Khan F. Cranial nerve non-invasive neuromodulation improves gait and balance in stroke survivors: a pilot randomized controlled trial. Brain Stimul. 2017;10:1133–5.
- PoNS: Heard of it! [Internet]. ALS Forums [cited 2023 September]. Available from: https://www.alsforums.com/community/threads/pons-heard-of-it.31429/.
- Long-Term Potentiation and Long-Term Depression [Internet]. Oxford Research Encyclopedia of Neuroscience [cited 2024 February]. Available from https://oxfordre.com/neuroscience/view/10.1093/acrefore/9780190264086.001.0001/acrefore-9780190264086-e-148.
- Leonard G, Lapierre Y, Chen JK, Wardini R, Crane J, Ptito A. Noninvasive tongue stimulation combined with intensive cognitive and physical rehabilitation induces neuroplastic changes in patients with multiple sclerosis: A multimodal neuroimaging study. Mult Scler J Exp Transl Clin. 2017;3:2055217317690561.
- D'Arcy RCN, Greene T, Greene D, Frehlick Z, Fickling SD, Campbell N, et al. Portable neuromodulation induces neuroplasticity to re-activate motor function recovery from brain injury: a high-density MEG case study. J Neuroeng Rehab. 2020;17:158.
- Wildenberg JC, Tyler ME, Danilov YP, Kaczmarek KA, Meyerand ME. Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation. Brain Imaging Behav. 2010;4:199–211.
- Frehlick Z, Lakhani B, Fickling SD, Livingstone AC, Danilov Y, Sackier JM, et al. Human translingual neurostimulation alters resting brain activity in high-density EEG. J Neuroeng Rehab. 2019;16:60.
- Ranieri F, Mariotto S, Dubbioso R, Di Lazzaro V. Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability. Front Neurol. 2020;11:605335.
- Edmond EC, Stagg CJ, Turner MR. Therapeutic non-invasive brain stimulation in amyotrophic lateral sclerosis: rationale, methods and experience. J Neurol Neurosurg Psychiatry. 2019;90:1131–8.
- Gulino R. Synaptic Dysfunction and Plasticity in Amyotrophic Lateral Sclerosis. Int J Mol Sci 2023;24:4613.
- DiLazzaro V, Oliviero A, Saturno E, Pilato F, Dileone M, Sabatelli M, et al. Motor cortex stimulation for amyotrophic lateral sclerosis. Time for a Therapeutic Trial? Clin Neurophys 2004;115:1479–85.
- Neuromodulation in MS Using Translingual Stimulation (NeuroMSTraLS) [Internet]. U.S. National Library of Medicine. [cited 2023 December]. Available from: https://classic.clinicaltrials.gov/ct2/show/study/NCT05275049.
- Di Lazzaro V, Dileone M, Pilato F, Profice P, Ranieri F, Musumeci G, et al. Repetitive transcranial stimulation for ALS. Neurosci Lett. 2006;408:135–40.
- Di Lazzaro V, Pilato F, Profice P, Ranieri F, Musumeci G, Florio L, et al. Motor cortex stimulation for ALS: a double blind placebo controlled trial. Neurosci Lett. 2009;464:18–21.
- Gonzalez-Bermejo J, Morelot-Panzini C, Tanguy M, Meininger V, Pradat P, Lenglet T, et al. Early diaphragmatic pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomized, controlled, triple-blind trial. Landet Neurol 2016;15:1217–27.
- Frequently asked questions [Internet]. Helius Medical Website [cited February 2024]. Available at https://ponstherapy.com/for-patients/frequently-asked-questions/
- FDA Approves Portable Nerve Stimulator for Use [Internet] National MS Society [Accessed 2024 February]. Available at https://www.nationalmssociety.org/About-the-Society/News/FDA-Approves-Portable-Nerve-Stimulator-for-Use-Dur#:∼:text=For%20the%20following%2012%20weeks,for%20the%20patient%20is%20%2414%2C500.
- Khangura SD. The Portable Neuromodulation Stimulator: Targeting Neuroplasticity for Balance or Gait Deficit. Cjht. 2021;1(8):4–10.
- PoNS Therapy [Internet]. Propel Physiotherapy 2023. https://propelphysiotherapy.com/physical-therapy-treatments/pons-therapy/
- Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis [Internet]. Globe Newswire. 2024. Available from: https://www.globenewswire.com/news-release/2023/01/05/2583587/0/en/Helius-Extends-its-Patient-Therapy-Access-Program-PTAP-Bringing-the-Benefits-of-its-PoNS-Device-to-More-People-with-Multiple-Sclerosis.html
- Isitan C, Yan Q, Spencer D, Alkawadri R. Brief history of electrical cortical stimulation: a journey in time from Volta to Penfield. Epilepsy Res. 2020;166:106363.
- Handa I, Matsushita N, Ihashi K, Yagi R, Mochizuki R, Mochizuki N, et al. A clinical trial of therapeutic electrical stimulation for amyotrophic lateral sclerosis. Tohoku J Exp Med. 1995;175:123–34.